Biopharmaceutical RFP, Characteristics & Outlook - April 2016

Published April 2016, 58 pages

This April 2016 study examines perceptions of 133 decision makers within large, mid–size and small pharmaceutical and biotechnology companies in North America and Europe on trends in the number, size, pricing, scope and therapeutic area(s) of interest of new RFPs/proposals sent to CROs for outsourced preclinical & clinical development work, key drivers of RFP volume and timing, and expected outlook of RFP volume within key preclinical and clinical development areas. The report is an update of the 2014 report.

Biopharmaceutical RFP, Characteristics & Outlook - April 2016
Click To Enlarge
  • Item #: 0014
  * Marked fields are required.
Qty*
Price $950.00